Collegium Pharmaceutical (COLL) Other Working Capital Changes (2017 - 2026)

Collegium Pharmaceutical has reported Other Working Capital Changes for 3 years, with the latest figure at -$166000.0 in Q2 2026.

• On a quarterly basis, Other Working Capital Changes fell 24.12% year-over-year to $8.2 million in Q2 2026; TTM through Jun 2026 was -$9.1 million, a 138.52% decrease from a year earlier, with the FY2025 full-year figure at $8.0 million, down 43.37% from the prior year.
• Other Working Capital Changes was $8.2 million for Q2 2026 at Collegium Pharmaceutical, up from -$4.1 million in the prior quarter.
• The five-year high for Other Working Capital Changes was $11.5 million in Q2 2024, with the low at -$21.3 million in Q3 2025.
• Average Other Working Capital Changes over 5 years is $1.6 million, with a median of $433000.0 recorded in 2022.
• The largest YoY upside for Other Working Capital Changes was 5703.39% in 2025 against a maximum downside of 5016.36% in 2025.
• Over 5 years, Other Working Capital Changes stood at $5.6 million in 2022, then plunged by 124.93% to -$1.4 million in 2023, then surged by 239.44% to $1.9 million in 2024, then soared by 320.17% to $8.2 million in 2025, then advanced by 0.57% to $8.2 million in 2026.
• The last three Other Working Capital Changes figures came in at $8.2 million (Q2 2026), -$4.1 million (Q1 2026), and $8.2 million (Q4 2025), per Business Quant data.